Bayesian Capital Management’s Cameco CCJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-39,100
Closed -$1.69M 776
2024
Q1
$1.69M Buy
+39,100
New +$1.71M 0.16% 181
2023
Q4
Sell
-17,400
Closed -$690K 778
2023
Q3
$690K Buy
+17,400
New +$616K 0.08% 294
2023
Q2
Sell
-19,600
Closed -$513K 819
2023
Q1
$513K Buy
+19,600
New +$518K 0.06% 383
2022
Q4
Sell
-47,600
Closed -$1.26M 810
2022
Q3
$1.26M Buy
+47,600
New +$1.22M 0.26% 101
2021
Q4
Sell
-16,700
Closed -$363K 393
2021
Q3
$363K Buy
+16,700
New +$316K 0.11% 229
2020
Q4
Sell
-11,800
Closed -$119K 473
2020
Q3
$119K Buy
+11,800
New +$128K 0.03% 471
2017
Q1
Sell
-28,651
Closed -$300K 435
2016
Q4
$300K Buy
+28,651
New +$259K 0.07% 428

Other funds holding CCJ

Bayesian Capital Management's CCJ Position: Q2 2024 in Review

Bayesian Capital Management sold out of Cameco (CCJ) in Q2 2024, closing a stake of 39,100 shares — an estimated $1.69M sold.

Bayesian Capital Management first reported a position in CCJ in Q4 2016 and held it in 7 quarters. The position peaked at $1.69M in Q1 2024. 641 funds tracked by Wall St. Rank hold CCJ as of Q2 2024.

  • Bayesian Capital Management reported no remaining Cameco position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 39,100 Cameco shares in Q2 2024, an estimated $1.69M.
  • Bayesian Capital Management first reported a position in Cameco in Q4 2016 and held it in 7 quarters.
  • Bayesian Capital Management's Cameco position peaked at $1.69M in Q1 2024.
  • 641 funds tracked by Wall St. Rank held Cameco as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.